LYVE1 and systemic sclerosis: To explore the possible presence of transitional Ly-EndMT cells, forearm skin sections obtained from the clinically affected skin of patients with SSc and from healthy donors were subjected to double fluorescence immunohistochemistry for the lymphatic EC-specific marker LYVE-1 in combination with α-SMA as a myofibroblast marker.